DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
Provided By GlobeNewswire
Last update: May 5, 2025
Châtillon, France, May 5, 2025
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Wednesday, May 7, 2025, at 11:00am ET, in New York, NY.
Read more at globenewswire.comNASDAQ:DBVT (6/10/2025, 8:00:01 PM)
9
+0.32 (+3.69%)
Find more stocks in the Stock Screener
